Evaluating the Efficacy of Eradicating Gardnerella vaginalis Vaginal Colonization With Amoxicillin: A Randomized, Double-Blind, Phase 2 Study. Issue 2 (February 2022)
- Record Type:
- Journal Article
- Title:
- Evaluating the Efficacy of Eradicating Gardnerella vaginalis Vaginal Colonization With Amoxicillin: A Randomized, Double-Blind, Phase 2 Study. Issue 2 (February 2022)
- Main Title:
- Evaluating the Efficacy of Eradicating Gardnerella vaginalis Vaginal Colonization With Amoxicillin
- Authors:
- McNeil, Candice J.
Tan, Amy
Powell, Jonathan A.
Pontius, Angela
Lewis, Andrea
Myler, Noelle
Schwebke, Jane R. - Abstract:
- Abstract : Background: Research suggests that Gardnerella vaginalis (GV) is the keystone pathogen in bacterial vaginosis (BV). Knowledge gaps exist regarding the role of GV eradication in the development of BV. This study was designed to test the hypothesis that vaginal colonization with GV could be eradicated by treatment of women without BV with amoxicillin, a drug highly active against GV. If GV is necessary for the development of BV, then eradication of GV may prevent the development of BV. Methods: We conducted a randomized control trial of amoxicillin 500 mg twice daily versus placebo for 7 days in women aged 18 to 45 years without vaginitis who screened positive for vaginal colonization with GV by quantitative polymerase chain reaction. Test-of-cure visit for GV was conducted at day 21. Results: One hundred seventy-two women met preliminary criteria and were screened for enrollment. Ninety-seven GV-positive women were randomized to receive amoxicillin versus placebo. Eradication of GV occurred in 21% of women randomized to amoxicillin versus 16% on placebo ( P = 0.757). In the 4 weeks between screening and test-of-cure visit, 16 of 92 (17%) of participants developed Nugent scores greater than 3 with 8 of 92 (9%) having BV. All of these were in participants in whom GV was not eradicated ( P = 0.035). Conclusions: The study failed to show a benefit of treatment with amoxicillin to eradicate GV. No participants in whom GV was eradicated had progression to abnormalAbstract : Background: Research suggests that Gardnerella vaginalis (GV) is the keystone pathogen in bacterial vaginosis (BV). Knowledge gaps exist regarding the role of GV eradication in the development of BV. This study was designed to test the hypothesis that vaginal colonization with GV could be eradicated by treatment of women without BV with amoxicillin, a drug highly active against GV. If GV is necessary for the development of BV, then eradication of GV may prevent the development of BV. Methods: We conducted a randomized control trial of amoxicillin 500 mg twice daily versus placebo for 7 days in women aged 18 to 45 years without vaginitis who screened positive for vaginal colonization with GV by quantitative polymerase chain reaction. Test-of-cure visit for GV was conducted at day 21. Results: One hundred seventy-two women met preliminary criteria and were screened for enrollment. Ninety-seven GV-positive women were randomized to receive amoxicillin versus placebo. Eradication of GV occurred in 21% of women randomized to amoxicillin versus 16% on placebo ( P = 0.757). In the 4 weeks between screening and test-of-cure visit, 16 of 92 (17%) of participants developed Nugent scores greater than 3 with 8 of 92 (9%) having BV. All of these were in participants in whom GV was not eradicated ( P = 0.035). Conclusions: The study failed to show a benefit of treatment with amoxicillin to eradicate GV. No participants in whom GV was eradicated had progression to abnormal vaginal flora during the study period. Abstract : Treatment with amoxicillin versus placebo showed no significant difference in eradicating Gardnerella vaginalis . Progression to abnormal vaginal flora did not occur in any woman with eradication of G. vaginalis . … (more)
- Is Part Of:
- Sexually transmitted diseases. Volume 49:Issue 2(2022)
- Journal:
- Sexually transmitted diseases
- Issue:
- Volume 49:Issue 2(2022)
- Issue Display:
- Volume 49, Issue 2 (2022)
- Year:
- 2022
- Volume:
- 49
- Issue:
- 2
- Issue Sort Value:
- 2022-0049-0002-0000
- Page Start:
- Page End:
- Publication Date:
- 2022-02
- Subjects:
- Sexually transmitted diseases -- Periodicals
Sexual health -- Periodicals
616.951005 - Journal URLs:
- http://gateway.ovid.com/ovidweb.cgi?T=JS&MODE=ovid&PAGE=toc&D=ovft&AN=00007435-000000000-00000 ↗
http://www.stdjournal.com ↗
http://journals.lww.com ↗ - DOI:
- 10.1097/OLQ.0000000000001555 ↗
- Languages:
- English
- ISSNs:
- 0148-5717
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 8254.486500
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 21276.xml